Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- ChecktodayChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a new version of the page. This appears to be a meta update indicating a page refresh or minor changes rather than core content changes.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the study record. This appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, signaling a maintenance update to the page's documentation rather than a modification to the study details.SummaryDifference0.0%

- Check50 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. No changes to study content or configuration are visible.SummaryDifference0.0%

- Check79 days agoChange DetectedFive new Virginia sites were added (Williamsburg, Newport News, Hampton, Chesapeake, Virginia Beach), bringing the total locations to 93. The study record was updated to revision v3.5.0 with completion dates noted.SummaryDifference0.6%

- Check86 days agoChange DetectedThe page revision updated from v3.4.2 to v3.4.3. This appears to be an administrative update to the page with no changes to study data.SummaryDifference0.0%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.